Skip to content

Advertisement

Fibrogenesis & Tissue Repair

What do you think about BMC? Take part in

Volume 5 Supplement 1

Proceedings of Fibroproliferative disorders: from biochemical analysis to targeted therapies

Proceedings

Edited by Petro E Petrides and David Brenner

Fibroproliferative disorders: from biochemical analysis to targeted therapies. Go to conference site.

Frauenchiemsee, Germany25-30 September 2010

Previous Page Page 1 of 2 Next Page
  1. Content type: Proceedings

    Lung development is a complex and finely balanced process. Yet the lung has a relatively limited repertoire of responses to injury, which, depending on severity of the injury and developmental stage and suscep...

    Authors: David Warburton

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S2

    Published on:

  2. Content type: Proceedings

    Novel approaches are needed to define subgroups of patients with Idiopathic pulmonary fibrosis (IPF) at risk for acute exacerbations and/or accelerated progression of this generally fatal disease. Progression ...

    Authors: Cory M Hogaboam, Glenda Trujillo and Fernando J Martinez

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S3

    Published on:

  3. Content type: Proceedings

    Myofibroblasts differentiate, invade and repair injured tissues by secreting and organizing the extracellular matrix and by developing contractile forces. When tissues are damaged, tissue homeostasis must be r...

    Authors: Ludovic Micallef, Nicolas Vedrenne, Fabrice Billet, Bernard Coulomb, Ian A Darby and Alexis Desmoulière

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S5

    Published on:

  4. Content type: Proceedings

    Fibrocytes, a group of bone marrow-derived mesenchymal progenitor cells, were first described in 1994 as fibroblast-like, peripheral blood cells that migrate to regions of tissue injury. These cells are unique...

    Authors: Adriana Blakaj and Richard Bucala

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S6

    Published on:

  5. Content type: Proceedings

    Several recent studies have demonstrated that endothelial to mesenchymal transition (EndoMT), a newly recognized type of cellular transdifferentiation may be an important source of myofibroblasts during the de...

    Authors: Sonsoles Piera-Velazquez and Sergio A Jimenez

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S7

    Published on:

  6. Content type: Proceedings

    Key roles for connective tissue growth factor (CTGF/CCN2) are demonstrated in the wound repair process where it promotes myofibroblast differentiation and angiogenesis. Similar mechanisms are active in tumor-r...

    Authors: Annica Jacobson and Janet L Cunningham

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S8

    Published on:

  7. Content type: Proceedings

    Lung fibrosis is the final common pathway of a large variety of chronic lung disorders, named interstitial lung diseases. The most aggressive form is the idiopathic pulmonary fibrosis [IPF] characterized by al...

    Authors: Annie Pardo and Moisés Selman

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S9

    Published on:

  8. Content type: Proceedings

    This review provides an introduction to mass spectrometry based proteomics and discusses several proteomics approaches that are relevant in understanding the pathophysiology of fibrotic disorders and the appro...

    Authors: Marjan Gucek

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S10

    Published on:

  9. Content type: Proceedings

    The wound-healing process induced by chronic hepatitis C virus (HCV) infection triggers liver damage characterized by fibrosis development and finally cirrhosis. Liver Transplantation (LT) is the optimal surgi...

    Authors: Ricardo Gehrau, Valeria Mas, Kellie Archer and Daniel Maluf

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S11

    Published on:

  10. Content type: Proceedings

    Activated hepatic stellate cells (HSC) play a central role in scar formation that leads to liver fibrosis. The molecular mechanisms underlying this process are not fully understood. Microarray and bioinformati...

    Authors: Hideaki Shimada and Lakshman E Rajagopalan

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S12

    Published on:

  11. Content type: Proceedings

    Chronic toxicities of locoregional and systemic oncological treatments commonly develop in long-term cancer survivors. Amongst these toxicities, post-radiotherapeutic complications alter patient's quality of l...

    Authors: Saad Hamama, Sylvie Delanian, Virginie Monceau and Marie-Catherine Vozenin

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S13

    Published on:

  12. Content type: Proceedings

    Fibrotic disorders are commonplace, take many forms and can be life-threatening. No better example of this exists than the progressive fibrosis that accompanies all chronic renal disease. Renal fibrosis is a d...

    Authors: Tim D Hewitson

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S14

    Published on:

  13. Content type: Proceedings

    The vasculature of the kidney is a heterogeneous structure, whose functional integrity is essential for the regulation of renal function. Owing to the importance of the endothelium in vascular biology, chronic...

    Authors: Dominique Guerrot, Jean-Claude Dussaule, Panagiotis Kavvadas, Jean-Jacques Boffa, Christos E Chadjichristos and Christos Chatziantoniou

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S15

    Published on:

  14. Content type: Proceedings

    Most chronic liver diseases of all etiologies result in progressive liver fibrosis. Myofibroblasts produce the extracellular matrix, including type I collagen, which constitutes the fibrous scar in liver fibro...

    Authors: David A Brenner, Tatiana Kisseleva, David Scholten, Yong Han Paik, Keiko Iwaisako, Sayaka Inokuchi, Bernd Schnabl, Ekihiro Seki, Samuele De Minicis, Christoph Oesterreicher and Kojiro Taura

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S17

    Published on:

  15. Content type: Proceedings

    Fibrosis in systemic sclerosis (SSc), a complex polygenic disease associated with autoimmunity and proliferative/obliterative vasculopathy, shares pathobiologic features in common with other fibrosing illnesse...

    Authors: Swati Bhattacharyya, Jun Wei, Warren G Tourtellotte, Monique Hinchcliff, Cara G Gottardi and John Varga

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S18

    Published on:

  16. Content type: Proceedings

    Despite significant advances have been made in the recent years regarding organ-specific therapies, there is no approved 'disease-modifying' antifibrotic drug for systemic sclerosis (SSc) available to date. Al...

    Authors: Naoki Iwamoto and Oliver Distler

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S19

    Published on:

  17. Content type: Proceedings

    Primary Myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by a clonal myeloproliferation and a myelofibrosis. The concomitant presence of neoangiogenesis and osteosclerosis suggests a ...

    Authors: Marie-Caroline Le Bousse-Kerdilès

    Citation: Fibrogenesis & Tissue Repair 2012 5(Suppl 1):S20

    Published on:

Previous Page Page 1 of 2 Next Page

Advertisement